Drug Profile
JLP 1602
Alternative Names: JLP-1602Latest Information Update: 28 Apr 2020
Price :
$50
*
At a glance
- Originator Jeil Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 28 Apr 2020 No recent reports of development identified for research development in Diabetes-mellitus in South Korea
- 21 Mar 2016 Early research in Diabetes mellitus in South Korea (unspecified route) prior to March 2016 (Jeil Pharmaceutical's pipeline, March 2016)